NCT07684807

Brief Summary

This observational study will collect synchronized photoplethysmography (PPG) and electrocardiogram (ECG) recordings from approximately 50 healthy adult volunteers. Participants will wear the Corsano CardioWatch 297-2 and a reference ECG device simultaneously for approximately 24 hours, including standardized activities and free-lining conditions. The objective is to generate a high-quality paired ECG-PPG dataset to support the development and evaluation of artificial intelligence methods fro reconstructing ECG parameters, with a particular focus on QT/QTc, from PPG signals. The study will also evaluate the feasibility and usability of the wearable monitoring system.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
2mo left

Started Jul 2026

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress36%
Jul 2026Oct 2026

First Submitted

Initial submission to the registry

June 29, 2026

Completed
2 days until next milestone

Study Start

First participant enrolled

July 1, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 6, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2026

Last Updated

July 6, 2026

Status Verified

June 1, 2026

Enrollment Period

2 months

First QC Date

June 29, 2026

Last Update Submit

June 29, 2026

Conditions

Keywords

ECGPPGWearable deviceCardioWatchDigital Health

Outcome Measures

Primary Outcomes (1)

  • Completeness of paired recordings, synchronisation quality (offset/drift indicators), and proportion of usable segments for QT/QTc reference annotation

    Assessment of paired ECG-PPG recording completeness, synchronization quality using offset and drift indicators, and the proportion of usable segments for QT/QTc reference annotation

    24 hours

Secondary Outcomes (1)

  • Usability/comfort of Corsano CardioWatch 287-2 (questionnaire) and technical issue rates (e.g., sensor detachment, connectivity interruptions)

    24 hours

Study Arms (1)

Healthy adult volunteers

Approximately 50 healthy adult volunteers who will wear the Corsano CardioWatch 287-2 and a reference ECG device simultaneously for approximately 24 hours, including standardized activities and free-living monitoring, to collect synchronized ECG and PPG recordings

Device: Corsano CardioWatch 287-2Device: VivaLNK wearable ECG patch

Interventions

Wrist-worn wearable device used to collect continuous photoplethysmography (PPG) signals and related physiological data during the study. The device is used simultaneously with a reference ECG device to generate synchronized ECG-PPG datasets for AI algorithm development and evaluation.

Healthy adult volunteers

Continuous reference ECG device used as the gold standard for synchronized ECG recordings and QT/QTc reference annotation

Healthy adult volunteers

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Healthy adult volunteers, including hospital employees, recruited at a single clinical site.

You may qualify if:

  • Able to provide written informed consent.
  • Willing and able to comply with all study procedures and attend the required study visits.
  • Age ≥18 years.
  • Able to read or understand Dutch or English.

You may not qualify if:

  • Children/minors or vulnerable individuals.
  • Skin conditions or allergies preventing safe wear of the CardioWatch or ECG electrodes.
  • Any condition that, in the investigator's opinion, may interfere with study completion or data quality.
  • Compromised circulation, injury, or physical malformation at sensor sites.
  • Known clotting disorders or current prescription anticoagulant therapy.
  • Other health conditions preventing safe participation.
  • Wrist circumference \<14 cm or \>23 cm.
  • Any participant who, in the investigator's opinion, does not meet study requirements

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 29, 2026

First Posted

July 6, 2026

Study Start

July 1, 2026

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

October 1, 2026

Last Updated

July 6, 2026

Record last verified: 2026-06